Reading vendor pricing pages: the 7 red flags that cost patients money

The vendor pricing page is where most patients make their first commitment decision. The page is also designed by marketing teams to optimize conversion, which means the information presentation favors the vendor's economics, not the patient's. Most patients don't read these pages critically because they assume the headline number is what they'll pay.

The 7 patterns below show up reliably on weaker vendor sites and cost patients money or steer them toward wrong choices.

Red flag 1: Headline price for the wrong dose

The page advertises "tirzepatide from $99/month" prominently. Buried in the smaller text or only revealed at checkout: that's the 2.5mg starter price. The 5mg-and-above doses (which is what almost everyone needs long-term) cost 2-4x more.

Why this matters: the pricing your eye lands on isn't the pricing you'll actually pay. A vendor with a $99 starter that becomes $299 at 5mg is in the same effective price tier as a vendor with transparent $299 pricing. The patient who thinks they're getting a $99 deal feels betrayed when the price escalates; the patient who walked into the $299 deal feels neutral.

How to spot it: scroll past the hero pricing. Find the "by dose" or "all doses" pricing table. The price you'll actually pay is the 5mg or higher dose price.

Red flag 2: No mention of the consultation fee

The drug pricing is shown clearly but the consultation cost is vague or absent. At checkout, a $200-300 consultation appears that wasn't visible anywhere on the pricing page. This is more common at premium-positioned operators that don't want to lead with the consultation cost.

How to spot it: look for "starting at" wording on the pricing page. Search the page for "consultation" or "appointment fee." If the page doesn't address consultation cost, it's almost always an additional charge.

Red flag 3: Quarterly or annual pricing as the only option visible

The page shows "$249/month when you purchase the 12-month plan." The single-month price isn't shown. The implication is that you're committing to 12 months on day one to get that price. The actual reality is that the single-month price is much higher (often 2x), and the 12-month commitment may be non-refundable.

Why this is predatory: weight loss outcomes are uncertain. A 12-month commitment is a bad financial decision until you know if the drug works for you. Vendors that hide the single-month pricing are gambling on customers committing to the higher-margin annual plan and not asking questions.

How to spot it: look for a single-month or per-month-no-commitment price. If you can't find it, the vendor is hiding it deliberately. Either ask explicitly or move on.

Red flag 4: "Free shipping" and "free consultation" framing where the costs are bundled

The pricing page emphasizes "FREE shipping! FREE consultation!" The consultation is genuinely free, the shipping is genuinely included, but the drug price is 30-40% above market. The "free" components are funded by the markup on the drug itself.

This isn't necessarily wrong; bundled pricing is fine if it's transparent. The flag is when the pricing model is presented as a deal when it's actually a markup. Compare the all-in cost to vendors with separate pricing for the same drug; if the bundled vendor's all-in is meaningfully higher, the "free" components are paid for in the drug markup.

Red flag 5: No mention of who's prescribing or which pharmacy fulfills

The pricing is clear, the workflow is described, but the actual prescribing physician and dispensing pharmacy aren't named. This is a major flag. A legitimate operation names its prescriber (usually with state license verification possible) and its pharmacy.

What this often signals: a marketing front-end with a flexible network of prescribers and pharmacies that may or may not be licensed in your state. The actual provider you'll interact with may rotate. The pharmacy that fulfills your prescription may be different from the one that handles the next patient's prescription.

How to spot it: search the site for "prescribed by," "fulfilled by," or "our pharmacy." If the answer is vague ("our network of providers"), proceed cautiously. Ask explicitly before committing.

Red flag 6: Compounded marketed as "FDA approved"

This is a misleading framing that shows up on weaker compounded operators. Compounded tirzepatide is not FDA approved as a finished product. The active ingredient is FDA approved (the API molecule), but the compounded formulation is not. There's a regulatory framework for compounded drugs (503A licensing, USP guidelines) but it's distinct from FDA approval.

When a compounded operator says "FDA approved," they're conflating the API approval with the finished product, which is misleading. Legitimate Tier 2 compounders describe their drug accurately ("compounded from FDA-approved tirzepatide API in a 503A-licensed pharmacy") rather than the misleading shorthand.

How to spot it: the words "FDA approved" applied to compounded products. The accurate framing is "FDA-approved active ingredient" or "compounded by 503A-licensed pharmacy."

Red flag 7: Pricing too good to be true

Brand Mounjaro at the manufacturer's wholesale price is roughly $400-500 per month at 5mg. After distribution and pharmacy markup, retail prices range from $700-1,100 in the US private market. A vendor offering brand Mounjaro at $250/month is doing one of three things: deeply discounting (rare and unsustainable), bundling something off-balance-sheet, or selling something that isn't actually brand Mounjaro.

For compounded, the math is different (the API is significantly cheaper than the finished brand product), but the floor is still around $150-200 per month at 5mg-equivalent for legitimate compounded preparations. Below that is either Tier 3 quality, illegitimate sourcing, or a teaser price that escalates.

How to spot it: compare to the lowest reputable competitor. If your candidate vendor is more than 30% below the lowest reputable competitor for the same dose, the price gap is a flag, not a feature.

What the legitimate pricing page actually looks like

The signs of a vendor that's not doing the patterns above:

• Single-month pricing visible without scrolling
• Consultation fee explicitly addressed
• Per-dose pricing table showing 2.5mg through 15mg
• Named prescribing physician(s) with state/regional license verification
• Named compounding pharmacy or brand source
• Shipping cost visible
• Cancellation/refund terms in the FAQ
• Pricing competitive but not dramatically below market

The legitimate vendor's pricing page is sometimes less visually attractive than the predatory one. The patient who optimizes for clean design over information density is the patient who pays more.

What I'd actually do

If a vendor's pricing page is hiding any of the seven patterns above, ask explicitly via chat or email. The legitimate vendor answers in 1-2 sentences without hedging. The predatory vendor either doesn't respond or responds with marketing copy.

If three or more of the patterns are present, move on. There are enough good vendors that you don't need to negotiate with bad ones.

The Panya 11-signal rubric on vendor scorecards operationalizes this. The blog post is the explanation; the catalog is the running answer.